APC
COLL icon

Aspire Private Capital’s Collegium Pharmaceutical COLL Stock Holding History

Aspire Private Capital’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-130
Closed -$2K – 469
2019
Q2 		$2K Hold
130
– – ﹤0.01% 382
2019
Q1 		$2K Hold
130
– – ﹤0.01% 424
2018
Q4 		$2K Buy
+130
New +$2.22K ﹤0.01% 407

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Aspire Private Capital's COLL Position: Q3 2019 in Review

Aspire Private Capital sold out of Collegium Pharmaceutical (COLL) in Q3 2019, closing a stake of 130 shares — an estimated $2K sold.

Aspire Private Capital first reported a position in COLL in Q4 2018 and held it in 3 quarters. The position peaked at $2K in Q2 2019. 117 funds tracked by Wall St. Rank hold COLL as of Q3 2019.

  • Aspire Private Capital reported no remaining Collegium Pharmaceutical position as of Q3 2019 after selling out during the quarter.
  • Aspire Private Capital sold 130 Collegium Pharmaceutical shares in Q3 2019, an estimated $2K.
  • Aspire Private Capital first reported a position in Collegium Pharmaceutical in Q4 2018 and held it in 3 quarters.
  • Aspire Private Capital's Collegium Pharmaceutical position peaked at $2K in Q2 2019.
  • 117 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2019.

Based on Aspire Private Capital's 13F filing for Q3 2019, filed 12 Nov 2019.